Pfizer more likely to spin off its animal health unit than sell it, CEO says

Nevin Barich

Nevin Barich

Mar 12, 2012 – Industry Intelligence

LOS ANGELES , March 12, 2012 () – Pfizer CEO Ian Read said his company is more likely to spin off its animal health unit than sell it, Reuters reported March 12.

Read said that although no final decision has been made, there were clear attractions for shareholders in a tax-free spinoff of the operation.

Read took over as Pfizer CEO in December 2010. He is looking to shrink the group by divesting non-core businesses, including veterinary medicine and infant nutrition. The company is losing billions of dollars of revenue from cholesterol product Lipitor, and its nutrition business is widely expected to be sold outright for around US$10 billion.

The primary source of this article is Reuters, London, England, on March 12, 2012.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.


About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025 795

+1 (310) 558 0008
+1 (310) 558 0080 (FAX)

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.